Zosano Pharma Corp — Form D

Zosano Pharma Corp of FREMONT, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-20. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
James BarrettDirectorRichmond, VA
John RichardDirectorLondon, X0
Bruce SteelDirectorIrvine, CA
Kleanthis XanthopoulosDirectorCarlsbad, CA
Christopher KruegerExecutive OfficerNijmegen, P7
Nandan OzaExecutive OfficerFremont, CA
Thorsten von SteinExecutive OfficerFremont, CA
Vikram LambaDirectorBoston, MA
Vikram LambaExecutive OfficerBoston, MA
John WalkerDirectorBirmingham, AL
Konstantinos AlatarisDirectorSanta Clara, CA
Konstantinos AlatarisExecutive OfficerSanta Clara, CA
Joseph P HaganDirectorSan Diego, CA
Bruce D SteelDirectorFremont, CA
Kleanthis D XanthopoulosDirectorFremont, CA
Haley D LewisExecutive OfficerFremont, CA
Troy D WilsonDirectorFremont, CA
Donald D KellermanExecutive OfficerFremont, CA
Winnie D TsoExecutive OfficerFremont, CA
Eric D ScharinExecutive OfficerFremont, CA
Georgia D ErbezExecutive OfficerFremont, CA
M. James BarrettDirectorGERMANTOWN, MD
Peter DaddonaDirectorFremont, CA
Peter DaddonaExecutive OfficerFremont, CA
Kleanthis James XanthopoulosDirectorFremont, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2016-08-29D$7.5M$7.5M
2015-06-30D$300K
2015-02-03D$15.0M$15.0M
2014-12-04D$2.0M$1.3M
2014-03-05D$2.5M$2.5M

More